-+ 0.00%
-+ 0.00%
-+ 0.00%
Aptevo to present multispecific CD40 platform at SITC annual meeting
Share
Listen to the news
Aptevo to present multispecific CD40 platform at SITC annual meeting
  • Aptevo will present its multispecific platform at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting on Nov. 4-8, 2026.
  • The meeting is scheduled for the Phoenix Convention Center in Phoenix, Arizona.
  • The presentation will cover tumor-directed CD40-activating multispecific molecules aimed at boosting anti-tumor immunity in solid tumors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610140846ACCESSWRNAPR_____1236659) on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending